Men are less likely than women to survive some cancers: study
Men with particular cancers generally fare worse than women with the same cancers, according to a new study from Melbourne researchers.
Previous research has acknowledged sex as an important factor in the prognosis of some cancers at all ages, but few large-scale studies have investigated sex differences in cancer survival. Now, a population-based study led by the Cancer Council Victoria and the University of Melbourne has found that men have a survival disadvantage relative to women for 11 of the 25 cancer types investigated.
The study used cancer registry data for all patients aged 15–99 (240,801 men, 173,773 women) with selected first primary cancers diagnosed in Victoria from 1982–2015. It excluded non-melanoma skin cancer, sex-specific cancers, breast cancer and cancers notified via autopsy and death certificate only. The results were published in the journal Cancer Causes & Control.
The researchers found that five-year net survival for the 25 cancer types combined was lower for men than women, and the excess rate of death due to cancer was 13% higher for men compared with women. They wrote, “The survival disadvantage for men was significant for 11 cancers: head and neck, oesophagus, colon/rectum, pancreas, lung, bone, melanoma, mesothelioma, kidney, thyroid and non-Hodgkin lymphoma.
“In contrast, women had poorer prognosis than men for cancers of the bladder, renal pelvis and ureter. Sex differences in cancer survival have decreased since 1982 for colorectal and pancreatic cancer to the point where they are no longer apparent. In contrast, for lung cancer, the male survival disadvantage is worse today than previously.”
The researchers added that sex differences were generally greatest for people diagnosed at younger ages. For 12 cancer types, there were no differences in net survival.
The study concluded that men had worse survival rates than women for many cancers, particularly at middle age. The reasons were unexplained although there were some theories, such as differences in screening uptake, stage at diagnosis, co-morbidity prevalence, treatment modalities and health-related lifestyle behaviours.
Lead researcher Nina Afshar said more work needs to be done to identify reasons for the disparities so that governments could work to improve male and female survival rates for all cancers. She said, “Identifying and understanding the complex mechanisms behind sex differences in cancer survival will help to establish effective interventions to reduce inequalities and improve cancer outcomes for both men and women.”
As part of World Antibiotic Awareness Week (12–18 November 2018), NPS MedicineWise has...
Even minor changes in genetic sequences in HLA molecules can impact dramatically on immune...
Researchers have solved a longstanding mystery surrounding the protein complex AMPK, long thought...